SCHEMBL6833796

SCHEMBL6833796

N#Cc1ccc(NC(=O)c2noc3c2CN(C(=O)OCc2ccccc2)CC3)c(C(=O)O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 3/20 0.42
MEN1 O00255 2/20 0.42
MAPT P10636 2/20 0.42
ALOX15 P16050 2/20 0.42
KMT2A Q03164 2/20 0.42
GAA P10253 1/20 0.42
HPGD P15428 1/20 0.42
HSP90AA1 P07900 3/20 0.41
PTGDR2 Q9Y5Y4 6/20 0.40
TMEM97 Q5BJF2 2/20 0.40
SIGMAR1 Q99720 2/20 0.40
ALB P02768 1/20 0.40
TP53 P04637 1/20 0.40
USP2 O75604 1/20 0.40
POLB P06746 1/20 0.40
NR4A1 P22736 1/20 0.40
APEX1 P27695 1/20 0.40
PTPN7 P35236 1/20 0.40
RECQL P46063 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6915841 0.87 MEN1 (0.42) ALDH1A1HSD17B10MEN1MAPTALOX15
SCHEMBL6821803 0.77 ALDH1A1 (0.55) ALDH1A1HSD17B10MEN1MAPTALOX15
SCHEMBL6814319 0.71 SMN1; SMN2 (0.61) ALDH1A1HSD17B10MEN1MAPTKMT2A
SCHEMBL6830330 0.71 SLC16A3 (0.44) MAPTMCL1
SCHEMBL6830490 0.69 HIF1A (0.55) ALB
SCHEMBL6822210 0.69 ALDH1A1 (0.43) ALDH1A1MEN1KMT2AALBPOLB
SCHEMBL505149 0.69 GRM5 (0.49) ALDH1A1HSD17B10MEN1MAPTALOX15
SCHEMBL504820 0.68 GRM5 (0.54) ALDH1A1HSD17B10MEN1MAPTALOX15
SCHEMBL6835761 0.68 ALB (0.39) ALDH1A1KMT2AALB
SCHEMBL7413192 0.67 MEN1 (0.50) ALDH1A1HSD17B10MEN1MAPTALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 ALDH1A1 170/4885HSD17B10 2592/4885MEN1 4132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.